Skip to content

Clinical trials

Respiratory Insufficiency trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Insufficiency Country / region: France Clear all

123 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20042
20053
20061
20071
20082
20092
20105
20118
20129
20133
20141
201511
20166
20179
20187
20198
202011
20215
20222
20234
20246
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Unknown status25
Terminated13
Recruiting12
Withdrawn3
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris17
Poitiers University Hospital8
Centre d'Investigation Clinique et Technologique 8057
University Hospital, Bordeaux7
University Hospital, Montpellier7
University Hospital, Rouen7
University Hospital, Grenoble6
Hôpital Louis Mourier4
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche3
Centre Hospitalier Régional d'Orléans3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Insufficiency123
Neuromuscular Diseases8
Pulmonary Disease, Chronic Obstructive7
Respiratory Distress Syndrome7
Emergencies6
COVID-195
Dyspnea4
Hypercapnia4
Heart Failure3
Muscle Weakness3

Trials

Showing 26 to 50 of 123. Each trial links to its page on Pharma Observatory.

23 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.